Clinical trial to compare availability in the body of the active substance nicotine as well as patch adhesion of the newly developed patch LTS Nicotine TTS (18.6 cm2) vs. Nicotinell® (21 mg/24 h) in healthy smokers after single patch applicatio
Phase 1
- Conditions
- bioequivalence and patch adhesion trialtherapeutical indication not studiedMedDRA version: 20.0Level: PTClassification code: 10057852Term: Nicotine dependence Class: 100000004873MedDRA version: 20.0Level: PTClassification code: 10053325Term: Smoking cessation therapy Class: 100000004865MedDRA version: 20.0Level: LLTClassification code: 10008374Term: Cessation of smoking Class: 10041244Therapeutic area: Psychiatry and Psychology [F] - Behavior and Behavior Mechanisms [F01]
- Registration Number
- CTIS2023-503548-14-00
- Lead Sponsor
- TS LOHMANN Therapie-Systeme AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method